Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dependence01:17

Drug Dependence

1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.3K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Inhaled Medications01:23

Inhaled Medications

1.0K
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.0K
Stimulants01:29

Stimulants

1.3K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cervicofacial Actinomycosis Presenting as a Fistulized Neck Mass During Pregnancy: A Case Report.

Diagnostics (Basel, Switzerland)·2026
Same author

A Simulation-Based Mechanical System-Identification Framework for Non-Invasive Lung Diagnostics and Personalized Pulmonary Rehabilitation.

Life (Basel, Switzerland)·2026
Same author

Multimodal Autoencoder-Based Anomaly Detection Reveals Clinical-Radiologic Heterogeneity in Pulmonary Fibrosis.

Medical sciences (Basel, Switzerland)·2026
Same author

Innovative approaches in RSV prevention: The expanding role of monoclonal antibodies in protection for all infants.

Germs·2025
Same author

Correlations Between Inflammatory Biomarkers and COPD Severity in a Real-Life Setting.

Journal of clinical medicine·2025
Same author

The remarkable effects of the ionized medical water Asea<sup>®</sup> in 3 boys with Duchenne dystrophy: Three case reports.

World journal of methodology·2025

Related Experiment Video

Updated: Jul 9, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
10:44

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

Published on: May 24, 2017

ELECTRONIC CIGARETTE--A WAY OF SMOKING CESSATION?

Paraschiva Postolache, Roxana-Maria Nemeş, Raluca Ioana Şerban

    Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
    |July 25, 2015
    PubMed
    Summary

    Healthcare providers should exercise caution when recommending electronic cigarettes (ECs) for smoking cessation. Current evidence does not support their superiority over FDA-approved cessation aids, and long-term safety remains unknown.

    More Related Videos

    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
    09:30

    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

    Published on: January 18, 2018

    Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
    08:39

    Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

    Published on: August 25, 2018

    Related Experiment Videos

    Last Updated: Jul 9, 2026

    Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
    10:44

    Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System

    Published on: May 24, 2017

    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
    09:30

    A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol

    Published on: January 18, 2018

    Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
    08:39

    Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies

    Published on: August 25, 2018

    Area of Science:

    • Public Health
    • Addiction Medicine
    • Respiratory Medicine

    Background:

    • Physicians have an ethical duty to guide patients on smoking cessation.
    • Electronic cigarettes (ECs) are increasingly popular among smokers seeking cessation advice.
    • Current clinical practice requires evidence-based strategies for tobacco addiction treatment.

    Purpose of the Study:

    • To evaluate the current evidence regarding the efficacy and safety of ECs for smoking cessation.
    • To inform healthcare providers on advising patients about EC use.
    • To determine if ECs meet the criteria for standard clinical use in tobacco addiction therapy.

    Main Methods:

    • Review of available scientific literature on ECs and smoking cessation.
    • Analysis of data on EC efficacy compared to FDA-approved cessation methods.
    • Assessment of short-term safety data and long-term health risk unknowns.

    Main Results:

    • Electronic cigarettes have not demonstrated superiority over FDA-approved smoking cessation drugs.
    • ECs lack FDA approval for smoking cessation purposes.
    • Short-term safety studies indicate ECs can cause airway reactivity; long-term risks are undetermined.

    Conclusions:

    • Caution is advised when recommending ECs for smoking cessation due to insufficient evidence of efficacy and safety.
    • Further clinical and regulatory data are necessary before ECs can be integrated into standard tobacco addiction treatment.
    • The long-term health implications of EC use require comprehensive investigation.